CDC Urges Everyone 50 And Older To Get New Vaccine

This new vaccine is the latest defense against a painful condition that is more common among older adults. It might be time to get vaccinated against shingles if you’re 50 or older.

Vaccine

Folks in this age group — even people who are healthy — should get a new shingles vaccine sold under the name Shingrix, according to the Centers for Disease Control and Prevention.

The CDC’s vaccine recommendations include a shingles vaccine for adults age 50 and older. Previously, the CDC specified a different shingles vaccine, Zostavax, as the go-to prevention for shingles. However, that recommendation only applied to folks 60 and older. The CDC still recommends Zostavax as an effective treatment for shingles, but now says Shingrix is the better option for most people.

The new shingles vaccination recommendation was strongly supported, with the CDC’s Advisory Committee on Immunization Practices voting 14-1 to recommend Shingrix for the 50-and-older age group. That vote was made in October, but the details on which the committee based that decision were just recently released.

This new vaccine is the latest defense against a painful condition that is more common among older adults.

It might be time to get vaccinated against shingles if you’re 50 or older.

Folks in this age group — even people who are healthy — should get a new shingles vaccine sold under the name Shingrix, according to the Centers for Disease Control and Prevention.

The CDC’s vaccine recommendations include a shingles vaccine for adults age 50 and older. Previously, the CDC specified a different shingles vaccine, Zostavax, as the go-to prevention for shingles. However, that recommendation only applied to folks 60 and older. The CDC still recommends Zostavax as an effective treatment for shingles, but now says Shingrix is the better option for most people.

The new shingles vaccination recommendation was strongly supported, with the CDC’s Advisory Committee on Immunization Practices voting 14-1 to recommend Shingrix for the 50-and-older age group. That vote was made in October, but the details on which the committee based that decision were just recently released.

The CDC’s Advisory Committee on Immunization Practices reports that clinical trials found the vaccine is more than 90 percent effective in preventing shingles in folks age 50 and older. Zostavax, by contrast, is anywhere from 38 percent to 70 percent effective, depending on age.

AARP reports that insurance companies will be more likely to cover Shingrix in light of the CDC’s official recommendation. GlaxoSmithKline notes that broad coverage is expected to kick in starting in this month.

That should give you ample time to talk to your doctor about whether a shingles vaccine is best for you.

About the Author

Leave A Response